MK-677 Raises Leptin But Doesn't Reduce Body Fat in Obese Men
MK-677 paradoxically increased leptin levels without reducing total body fat, and also raised testosterone while not affecting thyroid hormones, suggesting complex metabolic interactions beyond simple GH effects.
Quick Facts
What This Study Found
MK-677 increased serum leptin levels independent of body fat changes, increased testosterone, and had no effect on thyroid hormones in obese males, revealing metabolic effects dissociated from fat mass changes.
Key Numbers
How They Did This
Randomized, double-blind, placebo-controlled parallel study in obese males. MK-677 25 mg/day or placebo for 8 weeks. Leptin, thyroid hormones, testosterone, and body composition measured.
Why This Research Matters
The leptin-fat disconnection suggests MK-677 directly affects adipocyte signaling. If MK-677 raises leptin without reducing fat, its metabolic effects are more complex than simple GH-mediated fat burning.
The Bigger Picture
The assumption that GH secretagogues simply boost GH which then burns fat is too simplistic. MK-677's effects on leptin and other hormones suggest it modulates the metabolic network in ways that don't always align with GH effects alone.
What This Study Doesn't Tell Us
Short 8-week duration may be insufficient for fat mass changes. The mechanism of leptin increase independent of fat mass is unknown. Small sample in obese males only.
Questions This Raises
- ?Does MK-677 directly stimulate leptin production from fat cells?
- ?Would longer treatment eventually reduce fat mass?
- ?Does the testosterone increase have clinical significance?
Trust & Context
- Key Stat:
- Leptin-fat disconnect Leptin rose significantly during MK-677 treatment despite no change in total body fat, suggesting direct adipocyte effects
- Evidence Grade:
- Strong evidence from a well-designed RCT with comprehensive hormonal measurements, revealing unexpected metabolic findings.
- Study Age:
- Published in 1999. The complex metabolic effects of GH secretagogues continue to be studied.
- Original Title:
- Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.
- Published In:
- Clinical endocrinology, 50(4), 451-6 (1999)
- Authors:
- Svensson, J(6), Carlsson, B(2), Carlsson, L M, Jansson, J O, Bengtsson, B A
- Database ID:
- RPEP-00564
Evidence Hierarchy
Frequently Asked Questions
Does MK-677 help with fat loss?
This study found MK-677 didn't reduce body fat over 8 weeks despite increasing GH and other hormones. It increased lean mass (as shown in related studies) but fat loss may require longer treatment or additional interventions.
What does the leptin increase mean?
Leptin is a hormone from fat cells that regulates appetite. MK-677 raised leptin without changing fat mass, suggesting it directly affects fat cell signaling. This could have implications for appetite and metabolic regulation.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00564APA
Svensson, J; Carlsson, B; Carlsson, L M; Jansson, J O; Bengtsson, B A. (1999). Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.. Clinical endocrinology, 50(4), 451-6.
MLA
Svensson, J, et al. "Discrepancy between serum leptin values and total body fat in response to the oral growth hormone secretagogue MK-677.." Clinical endocrinology, 1999.
RethinkPeptides
RethinkPeptides Research Database. "Discrepancy between serum leptin values and total body fat i..." RPEP-00564. Retrieved from https://rethinkpeptides.com/research/svensson-1999-discrepancy-between-serum-leptin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.